Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Hematology-Oncology Fellowship, Medicine, Duke University School of Medicine 2014 - 2017
  • Internal Medicine Residency, Baylor College of Medicine 2011 - 2014
  • MD./PhD., University of Texas MD Anderson Cancer Center 2011
• 

  Duke Appointment History

  • Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2017 - 2018
• Research
• 

  Selected Grants

  • BLU-285-1303 awarded by Blueprint Medicines Corporation 2018 - 2023
  • Genmab GCT1021-01 awarded by Genmab A/S 2018 - 2023
  • AstraZeneca REFMAL 435 awarded by AstraZeneca Pharmaceuticals, LP 2017 - 2022
  • RIFTOS MKI (Bayer Observational Study) Number 17852 NX1401 awarded by Bayer Healthcare Pharmaceuticals Inc 2015 - 2020
  • Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer awarded by National Institutes of Health 2014 - 2020
  • Anti-Tumor Effects of locally and Systemically Administered EZN-2279 monotherapy in a murine model of Colorectal Carcinoma awarded by Leadiant Biosciences, Inc. 2017 - 2018

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.